A study published in Diabetes Care has found that incretin-based therapies, including liraglutide and sitagliptin, may offer ...

Using continuous glucose monitors, behavioural insights, and one of Europe’s most comprehensive datasets, the startup is ...

Dexcom's CGM portfolio is also diversified. Its products include its G series -- which is currently in its seventh iteration ...

The Sinocare GlucoMen iCan and the Abbott FreeStyle Libre 3. [Images courtesy of the companies]The Unified Patent Court (UPC) ...

Dexcom (Nasdaq:DXCM) said today that it has officially opened its manufacturing and office development in Athenry, Ireland.

Ketone detection translates chemical presence into measurable electrical signals using signal conversion, amplification, and ...

San Diego, California-based DexCom, Inc. (DXCM) is a medical technology company focused on continuous glucose monitoring (CGM ...

The multi-billion dollar CGM market is expected to experience substantial, double-digit percentage growth over the next five ...

In 1999, the U.S. Food and Drug Administration approved continuous glucose monitoring (CGM), a medical device that uses a ...

Wearable technologies are starting to reshape how people manage health. Continuous glucose monitors that measure blood sugar ...

Senseonics VP of Product Development Hari Sree explains the tech behind the Eversense 365-day CGM and what’s next in the ...

The market for modern health monitoring devices is rapidly developing worldwide. What is your vision of the current situation ...